Literature DB >> 10037099

Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.

S D Hursting1, T J Slaga, S M Fischer, J DiGiovanni, J M Phang.   

Abstract

Humans are exposed to a wide variety of carcinogenic insults, including endogenous and man-made chemicals, radiation, physical agents, and viruses. The ultimate goal of carcinogenesis research is to elucidate the processes involved in the induction of human cancer so that interventions may be developed to prevent the disease, either in the general population or in susceptible subpopulations. Progress to date in the carcinogenesis field, particularly regarding the mechanisms of chemically induced cancer, has revealed several points along the carcinogenesis pathway that may be amenable to mechanism-based prevention strategies. The purpose of this review is to examine the basic mechanisms and stages of chemical carcinogenesis, with an emphasis on ways in which preventive interventions can modify those processes. Possible ways of interfering with tumor initiation events include the following: i) modifying carcinogen activation by inhibiting enzymes responsible for that activation or by direct scavenging of DNA-reactive electrophiles and free radicals; ii) enhancing carcinogen detoxification processes by altering the activity of the detoxifying enzymes; and iii) modulating certain DNA repair processes. Possible ways of blocking the processes involved in the promotion and progression stages of carcinogenesis include the following: i) scavenging of reactive oxygen species; ii) altering the expression of genes involved in cell signaling, particularly those regulating cell proliferation, apoptosis, and differentiation; and iii) decreasing inflammation. In addition, the utility for mechanism-based cancer prevention research of new animal models that are based on the overexpression or inactivation of specific cancer-related genes is examined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037099     DOI: 10.1093/jnci/91.3.215

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  34 in total

Review 1.  Cancer chemoprevention.

Authors:  Peter Greenwald
Journal:  BMJ       Date:  2002-03-23

Review 2.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

3.  BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.

Authors:  Ram Fridlich; Devi Annamalai; Rohini Roy; Giana Bernheim; Simon N Powell
Journal:  DNA Repair (Amst)       Date:  2015-03-17

4.  Investigation of the extracts from Bidens pilosa Linn. var. radiata Sch. Bip. for antioxidant activities and cytotoxicity against human tumor cells.

Authors:  Jianguo Wu; Zhongxian Wan; Jun Yi; Yanbin Wu; Wei Peng; Jinzhong Wu
Journal:  J Nat Med       Date:  2012-03-01       Impact factor: 2.343

5.  Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer.

Authors:  Deacqunita L Diggs; Kelly L Harris; Perumalla V Rekhadevi; Aramandla Ramesh
Journal:  Tumour Biol       Date:  2012-03-20

6.  Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.

Authors:  Sebastian Brandhorst; Min Wei; Saewon Hwang; Todd E Morgan; Valter D Longo
Journal:  Exp Gerontol       Date:  2013-02-21       Impact factor: 4.032

Review 7.  The preneoplastic phenotype in murine mammary tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

8.  MicroRNA: A New Player for Cancer Chemoprevention.

Authors:  Yaguang Xi
Journal:  J Integr Oncol       Date:  2013

Review 9.  Calorie restriction and cancer prevention: metabolic and molecular mechanisms.

Authors:  Valter D Longo; Luigi Fontana
Journal:  Trends Pharmacol Sci       Date:  2010-01-25       Impact factor: 14.819

10.  Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.

Authors:  Masahito Shimizu; Yohei Shirakami; Hisataka Moriwaki
Journal:  Int J Mol Sci       Date:  2008-06-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.